Journal Watch · Proceedings of the National Academy of Sciences (PNAS) · 2026
<i>Candida</i> in the lower respiratory tract induces barrier disruption in mice and predicts poor outcomes in mechanically ventilated humans.
These findings establish that LRT <i>Calb</i> causes direct air-blood barrier disruption through hyphal morphogenesis and amplifies bacterial lung injury, challenging the prevailing view of <i>Candida</i> as an innocent respiratory bystander.
TL;DR
These findings establish that LRT <i>Calb</i> causes direct air-blood barrier disruption through hyphal morphogenesis and amplifies bacterial lung injury, challenging the prevailing view of <i>Candida</i> as an innocent respiratory bystander.
Key findings
- In human cohort data, LRT microbiome profiles with high <i>Calb</i> abundance and codominant bacterial pathogens predicted worse mortality, and mouse models confirmed that <i>Calb</i> amplifies lung barrier disruption when followed by <i>Pseudomonas aeruginosa</i> inoculation, an effect requiring hyphal morphogenesis.
- These findings establish that LRT <i>Calb</i> causes direct air-blood barrier disruption through hyphal morphogenesis and amplifies bacterial lung injury, challenging the prevailing view of <i>Candida</i> as an innocent respiratory bystander.
What they did
In a murine model, intratracheal <i>Calb</i> was sufficient to disrupt the air-blood barrier and recruit neutrophils, effects markedly attenuated with heat-killed <i>Calb</i>. Neutrophil depletion led to uncontrolled fungal growth, systemic dissemination and mortality, with surviving mice exhibiting worsened barrier disruption, demonstrating that neutrophils support pathogen control while lung injury is driven by the live organism. <i>Calb</i> induced lung epithelial cytotoxicity as well as barrier disruption in human alveolar epithelial cells at air liquid interface. Yeast-locked mutants without hyphal morphogenesis demonstrated attenuated barrier disruption in human alveolar cells and diminished lung injury in mice, despite higher fungal burden.
Full abstract (original)
Background: <i>Candida albicans</i> (<i>Calb</i>) in the lower respiratory tract (LRT) is considered a rare cause of pneumonia, yet its frequent recovery from LRT secretions of mechanically ventilated patients associates with poor clinical outcomes. To determine whether <i>Calb</i> contributes to lung injury, we conducted a translational investigation spanning two independent, prospective human cohorts, murine models of lung injury, and in vitro assays. In critically ill patients, <i>Calb</i> was the most abundant fungus in LRT specimens, and its detection associated with increased markers of lung injury, prolonged mechanical ventilation, and increased mortality.
What they did: In a murine model, intratracheal <i>Calb</i> was sufficient to disrupt the air-blood barrier and recruit neutrophils, effects markedly attenuated with heat-killed <i>Calb</i>. Neutrophil depletion led to uncontrolled fungal growth, systemic dissemination and mortality, with surviving mice exhibiting worsened barrier disruption, demonstrating that neutrophils support pathogen control while lung injury is driven by the live organism. <i>Calb</i> induced lung epithelial cytotoxicity as well as barrier disruption in human alveolar epithelial cells at air liquid interface. Yeast-locked mutants without hyphal morphogenesis demonstrated attenuated barrier disruption in human alveolar cells and diminished lung injury in mice, despite higher fungal burden.
Results & conclusions: In human cohort data, LRT microbiome profiles with high <i>Calb</i> abundance and codominant bacterial pathogens predicted worse mortality, and mouse models confirmed that <i>Calb</i> amplifies lung barrier disruption when followed by <i>Pseudomonas aeruginosa</i> inoculation, an effect requiring hyphal morphogenesis. These findings establish that LRT <i>Calb</i> causes direct air-blood barrier disruption through hyphal morphogenesis and amplifies bacterial lung injury, challenging the prevailing view of <i>Candida</i> as an innocent respiratory bystander.
Abstract © the authors / Proceedings of the National Academy of Sciences (PNAS) (2026). Reproduced here for discussion and indexing, with attribution. Read the original at https://doi.org/10.1073/pnas.2608378123 · PubMed 42766739.
Why it matters for pharma & biotech
- Directly relevant to teams in microbiome therapeutics — the abstract reports new data in that space, so competitive and pipeline teams should read the full text.
- Because it reports human data, it can inform indication, endpoint and comparator decisions faster than preclinical work.
- For searchers: the full abstract is reproduced below, so you can judge relevance before opening the publisher page.
Modalities & themes detected: microbiome therapeutics
Limitations & what to check in the full text
- This brief is based on the published abstract only. Effect sizes, subgroup results and safety detail in the full text may qualify the headline findings.
- The abstract reports its conclusions qualitatively, without headline effect sizes — read the full text before citing a magnitude.
Frequently asked questions
What did this Proceedings of the National Academy of Sciences (PNAS) study find?
These findings establish that LRT <i>Calb</i> causes direct air-blood barrier disruption through hyphal morphogenesis and amplifies bacterial lung injury, challenging the prevailing view of <i>Candida</i> as an innocent respiratory bystander.
What type of study is this?
It is a cohort / observational clinical study, published in Proceedings of the National Academy of Sciences (PNAS) in 2026. In a murine model, intratracheal <i>Calb</i> was sufficient to disrupt the air-blood barrier and recruit neutrophils, effects markedly attenuated with heat-killed <i>Calb</i>.
Where can I read the original paper?
The original is at the publisher via DOI 10.1073/pnas.2608378123. PubMed ID: 42766739. BioStudioAI reproduces the abstract for discussion and links to the source.
This brief: BioStudioAI Journal Watch, 29 October 2026. https://biostudioai.com/blog/papers/lt-i-gt-candida-lt-i-gt-in-the-lower-respiratory-tract-induces-barrier-d-378123/
Reading papers is step one. Analysing the data is the work.
BioStudioAI turns raw lab files into QC'd results, statistics, figures, reports and slides — hosted on your servers, every number computed, nothing typed.
Open BioStudioAI More guides